华昊中天医药(02563.HK) 表示,由于仍在收集及整理核数师完成审核程序所需主要涉及三项分别的投资的必要资料及文件,需要额外时间编制截至2024年12月31日止年度的年度业绩,故将延迟刊发2024年度业绩。
华昊中天医药已申请其股份自今日(1日)上午9时正起暂停在联交所买卖,以待刊发2024年度业绩。(gc/w)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.